There are 2 papers on Boerhaave syndrome in aging research: none in people yet.
2 papers study it1 more mentions it2 findings
1 new paper in 30 daysSee all 3 papers on Boerhaave syndrome
“persistent vomiting after self-escalation of a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist prescribed for weight loss, culminating in a contained oesophageal perforation.”
Associations
2Semaglutide
upin humans1
1 study
Semaglutide
upin humans1
Semaglutide is associated with Boerhaave syndrome in humans (semaglutide therapy for weight loss).
“a 62-year-old female patient who developed Boerhaave syndrome two days after initiating semaglutide therapy for weight loss.”
Humanssemaglutide therapy for weight lossesophagustwo days after initiationfemalesn = 1
Boerhaave Syndrome: Case Report on a Rare Complication of Semaglutide Use
Cureus
gip/GLP-1 receptor agonists
upin humans1
1 study
gip/GLP-1 receptor agonists
upin humans1
gip/GLP-1 receptor agonists raise the risk of Boerhaave syndrome in humans following severe vomiting induced by dose escalation.
“persistent vomiting after self-escalation of a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist prescribed for weight loss, culminating in a contained oesophageal perforation.”
Human trialfollowing severe vomiting induced by dose escalationfemalesn = 1
Cureus